Sowell Financial Services LLC Aurinia Pharmaceuticals Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$10.0 - $14.52 $25,120 - $36,474	-2,512 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$12.3 - $18.73 $13,001 - $19,797	1,057 Added 72.65%	2,512 $31,000
Q4 2020 Jan 13, 2021	BUY	$12.94 - $16.05 $8,812 - $10,930	681 Added 87.98%	1,455 $20,000
Q3 2020 Nov 12, 2020	SELL	$13.19 - $16.66 $3,165 - $3,998	-240 Reduced 23.67%	774 $11,000
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $5,280 - $6,855	374 Added 58.44%	1,014 $16,000
Q4 2019 Feb 07, 2020	BUY	$3.88 - $21.42 $2,483 - $13,708	640 New	640 $12,000

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.26B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.